Soumen Bhattacharyya: Clinical Implications and Risks in Metformin-Induced Vitamin B12 Deficiency
Soumen Bhattacharyya, College Teacher in the Department of Physiology at RBC College for Women, shared a post on LinkedIn:
“Metformin, Vitamin B12 Deficiency and Homocysteine: An Overlooked Clinical Link.
Metformin remains the cornerstone therapy for due to its efficacy, safety, and cardiovascular benefits.
However, an important long-term adverse effect often goes under-recognized: vitamin B12 deficiency and its metabolic consequences.
What’s the mechanism?
Metformin interferes with the calcium-dependent absorption of the intrinsic factor–vitamin B12 complex in the terminal ileum.
Additional contributing factors include altered gut motility and possible bacterial overgrowth.
Over time, this leads to reduced serum B12 levels.
Why does this matter?
Vitamin B12 plays a critical role in the conversion of homocysteine to methionine.
When B12 levels fall:
- Homocysteine accumulates
- Leads to a state of hyperhomocysteinemia
Clinical implications:
- Peripheral neuropathy (may mimic or worsen diabetic neuropathy)
- Megaloblastic anemia
- Increased cardiovascular risk associated with elevated homocysteine
What does the evidence say?
- Long-term metformin therapy is significantly associated with reduced B12 levels (de Jager et al., 2010)
- Reviews highlight impaired absorption as the primary mechanism (Niafar et al., 2021)
- Systematic analyses show increased homocysteine, particularly without vitamin supplementation (Aroda et al., 2016)
Clinical takeaway:
- Consider periodic monitoring of vitamin B12 in long-term metformin users
- Supplementation (oral or parenteral) when deficiency is detected
- Evaluate unexplained neuropathy carefully—don’t attribute everything to diabetes
Key References:
- de Jager J et al. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. BMJ, 2010.
- Niafar M et al. Long-term metformin therapy and vitamin B12 deficiency. (Review, PMC8311483)
- Aroda VR et al. Metformin and vitamin B12 deficiency: a systematic review.
A simple intervention—monitoring B12—can prevent significant morbidity in millions of patients on metformin.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?